278
Participants
Start Date
July 31, 2012
Primary Completion Date
July 31, 2015
Study Completion Date
November 30, 2016
Cx601
120 million cells administered by intralesional injection.
Saline solution
24 mL saline solution by intralesional injection
Medizinische Universität, Vienna
Leuven University Hospital, Leuven
CHU de Bordeaux, Bordeaux
Hospital Oost-Limburg, Genk
Catharina Ziekenhuis, Eindhoven
Univ.-Klinik Innsbruck, Innsbruck
Hospital Hartziekenhuis, Roeselare
Gent University Hospital, Ghent
Krankenhaus, Saint Veit/Glan
Charite, Berlin
CHU de Marseille, Marseille
CHU de Caen, Caen
Krakenhaus Walfriede, Berlin
Instituto Clinico Humanitas IRCCS, Milan
Klinikum Lüneburg, Lüneburg
Hospital Ramón y Cajal, Madrid
Fundacion Jimenez Diaz, Madrid
Rambam MC, Haifa
Azienda Ospedaliera di Padova, Padua
Klinikum Braunscheweig, Braunschweig
Hospital de Manises, Manises
Rabin MC, Petah Tikva
Azienda Ospedaliero-Universitaria Careggi, Florence
Evangelisches Krankenhaus Kalk, Cologne
Sheba MC, Tel Litwinsky
CHRU de Lille, Lille
Klinikum Frankfurt, Frankfurt am Main
Tel Aviv Sourasky MC, Tel Aviv
CHU d'Amiens, Amiens
Sharee Zedek MC, Jerusalem
Hôpital Beaujon, Clichy
Hôpital Saint-Louis, Paris
Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant'Orsola Malpighi, Bologna
Seconda Università degli Studi di Napoli, Napoli
AMC, Amsterdam
VUMC, Amsterdam
UMCU, Utrecht
Hospital Clinic de Barcelona, Barcelona
Hospital Universitario Reina Sofia, Córdoba
Hospital Juan Ramon Jimenez, Huelva
Hospital 12 de Octubre, Madrid
Hospital Clinico San Carlos, Madrid
Hospital La Princesa, Madrid
Hospital Universitario La Paz, Madrid
Hospital de Montecelo, Pontevedra
Hospital Virgen del Rocio, Seville
Hospital de Sagunto, Valencia
Hospital Universitario La Fe, Valencia
CHU de Nice, Nice
Azienda Ospedaliera San Camillo-Forlanini, Rome
Università Cattolica del Sacro Cuore, Rome
Son Espases, Palma de Mallorca
Tigenix S.A.U.
INDUSTRY